BVS Bioventus Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: BVS

Price (delayed)

$13.61

Market cap

$1.14B

P/E Ratio

16.8

Dividend/share

N/A

EPS

$0.81

Enterprise value

$1.36B

?
Relative Growth: Rel. Growth: 75
Relative Strength: Rel. Strength: 94
Relative Valuation: Rel. Valuation: 88
Relative Profitability: Rel. Profitability: 92
Highlights
The company's net income has surged by 91% QoQ
Bioventus's EPS has soared by 88% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Peers: OFIX

Key stats

What are the main financial stats of BVS

BVS stock price

How has the Bioventus stock price performed over time
Intraday
-0.29%
1 week
3.11%
1 month
-5.35%
1 year
96.68%
YTD
82.93%
QTD
44.17%

Financial performance

How have Bioventus's revenue and profit performed over time
Revenue
$581.85M
Gross profit
$399.45M
Operating income
$38.56M
Net income
$54.46M
Gross margin
68.7%
Net margin
9.4%
BVS's net margin has soared by 92% QoQ
The company's net income has surged by 91% QoQ
The operating income has grown by 15% from the previous quarter
Bioventus's operating margin has increased by 14% QoQ

Price vs fundamentals

How does BVS's price correlate with its fundamentals

Growth

What is Bioventus's growth rate over time

Valuation

What is Bioventus stock price valuation
P/E
16.8
P/B
4.98
P/S
1.59
EV/EBIT
26.47
EV/EBITDA
14.09
EV/Sales
2.34
Bioventus's EPS has soared by 88% from the previous quarter
BVS's price to earnings (P/E) is 39% less than its last 4 quarters average of 27.6
BVS's price to book (P/B) is 66% more than its 5-year quarterly average of 3.0 and 43% more than its last 4 quarters average of 3.5
Bioventus's equity has increased by 42% YoY and by 21% from the previous quarter
BVS's P/S is 77% above its 5-year quarterly average of 0.9 and 59% above its last 4 quarters average of 1.0
The revenue is up by 3.1% year-on-year

Efficiency

How efficient is Bioventus business performance
The return on assets has surged by 90% since the previous quarter
The ROE has soared by 74% since the previous quarter
The return on invested capital has surged by 64% year-on-year and by 4.8% since the previous quarter
Bioventus's ROS has increased by 44% YoY

Dividends

What is BVS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BVS.

Financial health

How did Bioventus financials performed over time
Bioventus's total assets is 70% more than its total liabilities
The quick ratio rose by 24% year-on-year and by 3.8% since the previous quarter
Bioventus's total liabilities has decreased by 22% YoY and by 4.9% QoQ
BVS's debt is 9% higher than its equity
BVS's debt to equity is down by 49% year-on-year and by 24% since the previous quarter
Bioventus's equity has increased by 42% YoY and by 21% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.